Team:Brasil-SP/Project/ResponseModule

From 2014.igem.org

(Difference between revisions)
Line 6: Line 6:
<p><div align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The reporter gene chosen for the output system was the GFP. The main reason for that choice was the simplicity in measuring its fluorescenchttps://2014.igem.org/Main_Pagee with the fluorimeter and flow cytometry, but it can be replaced by any other reporter system. In the final development stage of the project we envision a output that do not need to be excited like the GFP does.</p>
<p><div align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The reporter gene chosen for the output system was the GFP. The main reason for that choice was the simplicity in measuring its fluorescenchttps://2014.igem.org/Main_Pagee with the fluorimeter and flow cytometry, but it can be replaced by any other reporter system. In the final development stage of the project we envision a output that do not need to be excited like the GFP does.</p>
-
<div align="center"><img src="https://static.igem.org/mediawiki/2014/0/0e/Circuit_response.png" width="500" height="370"/></div>
+
<div align="left"><img src="https://static.igem.org/mediawiki/2014/0/0e/Circuit_response.png" width="500" height="370"/></div>
-
<div align="center"><img src="https://static.igem.org/mediawiki/2014/3/34/Indicator.png" width="400" height"240"/></div>
+
<div align="right"><img src="https://static.igem.org/mediawiki/2014/3/34/Indicator.png" width="400" height"240"/></div>
<p><div align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Note that the biossensor will perform a negative detection. In other words, when the patient is healthy we'll have no fluorescence, and when in a unhealthy situation the bacteria will not glow. In a more realistic approach, we do not expect our system to have only two intensities (zero or maximum glow). What might happen is that we'll have a more continuous spectrum of intensities, which would make it harder to differentiate between a negative and positive diagnosis. To deal with this problem we are adding a negative control in our <a href="https://2014.igem.org/Team:Brasil-SP/Results/Microfluidics">microfluidic device</a>. In this negative chamber there will be no blood serum in contact with our bacteria, therefore cathepsin S will work at full potencial generating a maximum LasR production and consequently maximum fluorescence.<p>
<p><div align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Note that the biossensor will perform a negative detection. In other words, when the patient is healthy we'll have no fluorescence, and when in a unhealthy situation the bacteria will not glow. In a more realistic approach, we do not expect our system to have only two intensities (zero or maximum glow). What might happen is that we'll have a more continuous spectrum of intensities, which would make it harder to differentiate between a negative and positive diagnosis. To deal with this problem we are adding a negative control in our <a href="https://2014.igem.org/Team:Brasil-SP/Results/Microfluidics">microfluidic device</a>. In this negative chamber there will be no blood serum in contact with our bacteria, therefore cathepsin S will work at full potencial generating a maximum LasR production and consequently maximum fluorescence.<p>

Revision as of 16:44, 13 October 2014

[[Image:{{{headersrc}}}|1079px]]

Response Module

     The reporter gene chosen for the output system was the GFP. The main reason for that choice was the simplicity in measuring its fluorescenchttps://2014.igem.org/Main_Pagee with the fluorimeter and flow cytometry, but it can be replaced by any other reporter system. In the final development stage of the project we envision a output that do not need to be excited like the GFP does.

     Note that the biossensor will perform a negative detection. In other words, when the patient is healthy we'll have no fluorescence, and when in a unhealthy situation the bacteria will not glow. In a more realistic approach, we do not expect our system to have only two intensities (zero or maximum glow). What might happen is that we'll have a more continuous spectrum of intensities, which would make it harder to differentiate between a negative and positive diagnosis. To deal with this problem we are adding a negative control in our microfluidic device. In this negative chamber there will be no blood serum in contact with our bacteria, therefore cathepsin S will work at full potencial generating a maximum LasR production and consequently maximum fluorescence.